Globus Medical, Inc.
GMED stock score: 66/100
$78.68 · -0.35% · Scored Oct 21, 2026
- Technical
- 58
- Fundamental
- 74
- News
- —
The reading
Globus Medical (GMED) scores 66 out of 100, which reads bullish, higher than 97% of Healthcare stocks and 92% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 58, fundamentals 74.
Among the fundamentals, Price Target at 100 and Earnings Growth (Annual) at 100 score highest, while Earnings Estimates at 25 weighs the most against it.
On the daily chart, trend-following indicators average 60 and contrarian oscillators 42.
Since Jul 25, 2026 the composite has ranged from 45 to 79, and it is down 11 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward GMED’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
74Pulling it up
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Earnings Growth (Annual)100
Annual earnings growth tracks year-over-year profit expansion.
- Current Ratio99
Current ratio measures ability to pay short-term liabilities with current assets.
Holding it back
- Earnings Estimates25
Earnings estimates score evaluates analyst projections for future profitability.
- Inventory Turnover28
Inventory turnover is how many times a year a company sells through its inventory.
- Insider Transactions35
Insider transactions track recent buying and selling by company insiders.
41 weighted scorers.
Technical · daily
54Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- VWAP93
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
- Stochastic (14)90
Stochastic Oscillator (14-period) compares the current price to its range over 14 periods.
Holding it back
- Candlestick Patterns0
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
- Bollinger Bands (20)5
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- SMA 200 Cross Up12
SMA 200 Cross Up tracks when faster moving averages cross above the 200-period SMA.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 58 | 1 |
| Daily | 54 | 3 |
| Weekly | 54 | 2 |
| Monthly | 62 | 2 |
| Quarterly | 64 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 21, 2026 | 66 |
| Oct 20, 2026 | 66 |
| Oct 19, 2026 | 62 |
| Oct 18, 2026 | 65 |
| Oct 17, 2026 | 64 |
| Oct 16, 2026 | 64 |
| Oct 15, 2026 | 66 |
| Oct 14, 2026 | 64 |
| Oct 13, 2026 | 64 |
| Oct 12, 2026 | 64 |
| Oct 11, 2026 | 61 |
| Oct 10, 2026 | 61 |
| Oct 9, 2026 | 61 |
| Oct 8, 2026 | 60 |
| Oct 7, 2026 | 63 |
| Oct 6, 2026 | 64 |
| Oct 5, 2026 | 64 |
| Oct 4, 2026 | 63 |
| Oct 3, 2026 | 63 |
| Oct 2, 2026 | 63 |
| Oct 1, 2026 | 61 |
| Sep 30, 2026 | 62 |
| Sep 29, 2026 | 63 |
| Sep 28, 2026 | 62 |
| Sep 27, 2026 | 62 |
| Sep 26, 2026 | 62 |
| Sep 25, 2026 | 62 |
| Sep 24, 2026 | 63 |
| Sep 23, 2026 | 62 |
| Sep 22, 2026 | 63 |
| Sep 21, 2026 | 62 |
| Sep 20, 2026 | 61 |
| Sep 19, 2026 | 61 |
| Sep 18, 2026 | 61 |
| Sep 17, 2026 | 61 |
| Sep 16, 2026 | 61 |
| Sep 15, 2026 | 61 |
| Sep 14, 2026 | 62 |
| Sep 13, 2026 | 60 |
| Sep 12, 2026 | 60 |
| Sep 11, 2026 | 60 |
| Sep 10, 2026 | 59 |
| Sep 9, 2026 | 60 |
| Sep 8, 2026 | 62 |
| Sep 7, 2026 | 63 |
| Sep 6, 2026 | 63 |
| Sep 5, 2026 | 63 |
| Sep 4, 2026 | 62 |
| Sep 3, 2026 | 63 |
| Sep 2, 2026 | 66 |
| Sep 1, 2026 | 66 |
| Aug 31, 2026 | 66 |
| Aug 30, 2026 | 68 |
| Aug 29, 2026 | 68 |
| Aug 28, 2026 | 68 |
| Aug 27, 2026 | 66 |
| Aug 26, 2026 | 67 |
| Aug 25, 2026 | 66 |
| Aug 24, 2026 | 68 |
| Aug 23, 2026 | 70 |
| Aug 22, 2026 | 70 |
| Aug 20, 2026 | 70 |
| Aug 19, 2026 | 70 |
| Aug 18, 2026 | 69 |
| Aug 17, 2026 | 69 |
| Aug 16, 2026 | 69 |
| Aug 15, 2026 | 70 |
| Aug 14, 2026 | 69 |
| Aug 13, 2026 | 70 |
| Aug 12, 2026 | 69 |
| Aug 11, 2026 | 69 |
| Aug 10, 2026 | 69 |
| Aug 9, 2026 | 69 |
| Aug 8, 2026 | 69 |
| Aug 7, 2026 | 70 |
| Aug 6, 2026 | 60 |
| Aug 5, 2026 | 60 |
| Aug 3, 2026 | 61 |
| Aug 2, 2026 | 58 |
| Jul 31, 2026 | 45 |
| Jul 30, 2026 | 46 |
| Jul 29, 2026 | 47 |
| Jul 28, 2026 | 79 |
| Jul 27, 2026 | 77 |
| Jul 26, 2026 | 77 |
| Jul 25, 2026 | 77 |
Key facts
- Market cap
- $10.6B
- Sector
- Healthcare
- Industry
- Medical Devices
- Beta
- 0.96
- Risk grade (1–10)
- 10
- Next earnings
- Nov 5, 2026
Medical Devices peers
| Company | Market cap | Score |
|---|---|---|
| SNN Smith & Nephew | $12.2B | 54 |
| GKOS Glaukos | $10.4B | 54 |
| TXG 10x Genomics | $9.8B | 50 |
| PODD Insulet | $9.8B | 54 |
| BIO Bio-Rad Laboratories | $9.6B | 53 |
| BRKR Bruker | $9.0B | 50 |
Questions
What is GMED's stock score today?
GMED scores 66/100 (Bullish) as of Oct 21, 2026: technical 58, fundamental 74. Scores are recomputed every night.
Is GMED a buy?
The score is not a buy or sell recommendation. A 66 says the technical and fundamental signals we measure lean bullish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the GMED score calculated?
103 weighted scorers feed it today: 41 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.